Thrombin-Activatable Fibrinolysis Inhibitor in Human Abdominal Aortic Aneurysm Disease

Bridge, KI, Bollen, L, Zhong, J et al. (7 more authors) (2017) Thrombin-Activatable Fibrinolysis Inhibitor in Human Abdominal Aortic Aneurysm Disease. Journal of Thrombosis and Haemostasis, 15 (11). pp. 2218-2225. ISSN 1538-7933

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 International Society on Thrombosis and Haemostasis. This is the peer reviewed version of the following article: Bridge KI, Bollen L, Zhong J, Hesketh M, Macrae FL, Johnson A, Philippou H, Scott DJ, Gils A, Ariёns RAS (2017) Thrombin-Activatable Fibrinolysis Inhibitor in Human Abdominal Aortic Aneurysm Disease. Journal of Thrombosis and Haemostasis; 15: 2218–2225, which has been published in final form at https://doi.org/10.1111/jth.13804. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: Abdominal aortic aneurysm; Carboxypeptidase B2; Fibrinolysis; Thrombin-activatable fibrinolysis inhibitor; Thrombosis
Dates:
  • Published: November 2017
  • Accepted: 10 August 2017
  • Published (online): 21 August 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Genetics, Health and Therapeutics (LIGHT) > Academic Unit of Cardiovascular Medicine (Leeds)
Funding Information:
FunderGrant number
Circulation FoundationNOT GIVEN
British Heart FoundationFS/12/26/29395
Depositing User: Symplectic Publications
Date Deposited: 22 Aug 2017 13:01
Last Modified: 22 Aug 2018 00:38
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1111/jth.13804

Share / Export

Statistics